The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Point of Care Testing for Infectious Disease-Global Market Insights and Sales Trends 2025
Synopsis
The global Point of Care Testing for Infectious Disease market size is expected to reach US$ 13440 million by 2029, growing at a CAGR of 10.0% from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care Testing for Infectious Disease in various end use industries. The expanding demands from the Hospital, Clinics and Others,, are propelling Point of Care Testing for Infectious Disease market. Immunological Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pathogen Nucleic Acid Test segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Point of Care Testing for Infectious Disease market, driven by demand from China, the second largest economy with some signs of stabilising, the Point of Care Testing for Infectious Disease market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care Testing for Infectious Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care Testing for Infectious Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care Testing for Infectious Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care Testing for Infectious Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care Testing for Infectious Disease covered in this report include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY and Sinocare, etc.
The global Point of Care Testing for Infectious Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Sinocare
Wondfo
Yuwell
Runbio
KHB
Global Point of Care Testing for Infectious Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care Testing for Infectious Disease market, Segment by Type:
Immunological Test
Pathogen Nucleic Acid Test
Global Point of Care Testing for Infectious Disease market, by Application
Hospital
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care Testing for Infectious Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Point of Care Testing for Infectious Disease market size is expected to reach US$ 13440 million by 2029, growing at a CAGR of 10.0% from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care Testing for Infectious Disease in various end use industries. The expanding demands from the Hospital, Clinics and Others,, are propelling Point of Care Testing for Infectious Disease market. Immunological Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pathogen Nucleic Acid Test segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Point of Care Testing for Infectious Disease market, driven by demand from China, the second largest economy with some signs of stabilising, the Point of Care Testing for Infectious Disease market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care Testing for Infectious Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care Testing for Infectious Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care Testing for Infectious Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care Testing for Infectious Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care Testing for Infectious Disease covered in this report include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY and Sinocare, etc.
The global Point of Care Testing for Infectious Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Sinocare
Wondfo
Yuwell
Runbio
KHB
Global Point of Care Testing for Infectious Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care Testing for Infectious Disease market, Segment by Type:
Immunological Test
Pathogen Nucleic Acid Test
Global Point of Care Testing for Infectious Disease market, by Application
Hospital
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care Testing for Infectious Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Point of Care Testing for Infectious Disease
1.1 Point of Care Testing for Infectious Disease Market Overview
1.1.1 Point of Care Testing for Infectious Disease Product Scope
1.1.2 Point of Care Testing for Infectious Disease Market Status and Outlook
1.2 Global Point of Care Testing for Infectious Disease Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Point of Care Testing for Infectious Disease Market Size by Region (2018-2029)
1.4 Global Point of Care Testing for Infectious Disease Historic Market Size by Region (2018-2023)
1.5 Global Point of Care Testing for Infectious Disease Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Point of Care Testing for Infectious Disease Market Size (2018-2029)
1.6.1 North America Point of Care Testing for Infectious Disease Market Size (2018-2029)
1.6.2 Europe Point of Care Testing for Infectious Disease Market Size (2018-2029)
1.6.3 Asia-Pacific Point of Care Testing for Infectious Disease Market Size (2018-2029)
1.6.4 Latin America Point of Care Testing for Infectious Disease Market Size (2018-2029)
1.6.5 Middle East & Africa Point of Care Testing for Infectious Disease Market Size (2018-2029)
2 Point of Care Testing for Infectious Disease Market by Type
2.1 Introduction
2.1.1 Immunological Test
2.1.2 Pathogen Nucleic Acid Test
2.2 Global Point of Care Testing for Infectious Disease Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Point of Care Testing for Infectious Disease Historic Market Size by Type (2018-2023)
2.2.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Point of Care Testing for Infectious Disease Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Point of Care Testing for Infectious Disease Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Point of Care Testing for Infectious Disease Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Point of Care Testing for Infectious Disease Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Point of Care Testing for Infectious Disease Revenue Breakdown by Type (2018-2029)
3 Point of Care Testing for Infectious Disease Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Others
3.2 Global Point of Care Testing for Infectious Disease Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Point of Care Testing for Infectious Disease Historic Market Size by Application (2018-2023)
3.2.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Point of Care Testing for Infectious Disease Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Point of Care Testing for Infectious Disease Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Point of Care Testing for Infectious Disease Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Point of Care Testing for Infectious Disease Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Point of Care Testing for Infectious Disease Revenue Breakdown by Application (2018-2029)
4 Point of Care Testing for Infectious Disease Competition Analysis by Players
4.1 Global Point of Care Testing for Infectious Disease Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point of Care Testing for Infectious Disease as of 2022)
4.3 Date of Key Players Enter into Point of Care Testing for Infectious Disease Market
4.4 Global Top Players Point of Care Testing for Infectious Disease Headquarters and Area Served
4.5 Key Players Point of Care Testing for Infectious Disease Product Solution and Service
4.6 Competitive Status
4.6.1 Point of Care Testing for Infectious Disease Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Point of Care Testing for Infectious Disease Products, Services and Solutions
5.1.4 Roche Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Point of Care Testing for Infectious Disease Products, Services and Solutions
5.2.4 Abbott Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 LifeScan
5.3.1 LifeScan Profile
5.3.2 LifeScan Main Business
5.3.3 LifeScan Point of Care Testing for Infectious Disease Products, Services and Solutions
5.3.4 LifeScan Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Healthineers Recent Developments
5.4 Siemens Healthineers
5.4.1 Siemens Healthineers Profile
5.4.2 Siemens Healthineers Main Business
5.4.3 Siemens Healthineers Point of Care Testing for Infectious Disease Products, Services and Solutions
5.4.4 Siemens Healthineers Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Healthineers Recent Developments
5.5 Danaher
5.5.1 Danaher Profile
5.5.2 Danaher Main Business
5.5.3 Danaher Point of Care Testing for Infectious Disease Products, Services and Solutions
5.5.4 Danaher Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.5.5 Danaher Recent Developments
5.6 Ascensia
5.6.1 Ascensia Profile
5.6.2 Ascensia Main Business
5.6.3 Ascensia Point of Care Testing for Infectious Disease Products, Services and Solutions
5.6.4 Ascensia Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.6.5 Ascensia Recent Developments
5.7 BioMerieux
5.7.1 BioMerieux Profile
5.7.2 BioMerieux Main Business
5.7.3 BioMerieux Point of Care Testing for Infectious Disease Products, Services and Solutions
5.7.4 BioMerieux Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.7.5 BioMerieux Recent Developments
5.8 ARKRAY
5.8.1 ARKRAY Profile
5.8.2 ARKRAY Main Business
5.8.3 ARKRAY Point of Care Testing for Infectious Disease Products, Services and Solutions
5.8.4 ARKRAY Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.8.5 ARKRAY Recent Developments
5.9 Sinocare
5.9.1 Sinocare Profile
5.9.2 Sinocare Main Business
5.9.3 Sinocare Point of Care Testing for Infectious Disease Products, Services and Solutions
5.9.4 Sinocare Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.9.5 Sinocare Recent Developments
5.10 Wondfo
5.10.1 Wondfo Profile
5.10.2 Wondfo Main Business
5.10.3 Wondfo Point of Care Testing for Infectious Disease Products, Services and Solutions
5.10.4 Wondfo Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.10.5 Wondfo Recent Developments
5.11 Yuwell
5.11.1 Yuwell Profile
5.11.2 Yuwell Main Business
5.11.3 Yuwell Point of Care Testing for Infectious Disease Products, Services and Solutions
5.11.4 Yuwell Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.11.5 Yuwell Recent Developments
5.12 Runbio
5.12.1 Runbio Profile
5.12.2 Runbio Main Business
5.12.3 Runbio Point of Care Testing for Infectious Disease Products, Services and Solutions
5.12.4 Runbio Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.12.5 Runbio Recent Developments
5.13 KHB
5.13.1 KHB Profile
5.13.2 KHB Main Business
5.13.3 KHB Point of Care Testing for Infectious Disease Products, Services and Solutions
5.13.4 KHB Point of Care Testing for Infectious Disease Revenue (US$ Million) & (2018-2023)
5.13.5 KHB Recent Developments
6 North America
6.1 North America Point of Care Testing for Infectious Disease Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Point of Care Testing for Infectious Disease Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Point of Care Testing for Infectious Disease Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Point of Care Testing for Infectious Disease Market Dynamics
11.1 Point of Care Testing for Infectious Disease Industry Trends
11.2 Point of Care Testing for Infectious Disease Market Drivers
11.3 Point of Care Testing for Infectious Disease Market Challenges
11.4 Point of Care Testing for Infectious Disease Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
